2003
DOI: 10.1016/j.neubiorev.2003.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
18
0

Year Published

2005
2005
2010
2010

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 82 publications
(83 reference statements)
1
18
0
Order By: Relevance
“…Recently Shaw and colleagues, proposed that the causal agents of ALS-PDC and other neurodegenerative disorders are sterol glucosides (Shaw and Wilson, 2003). This is consistent with their inability to observe any behavioral or neuropathological effects when they administered L-BMAA to mice (CruzAguado et al, 2006).…”
Section: In Vivo Studies Of Bmaa Neurotoxicitymentioning
confidence: 74%
See 4 more Smart Citations
“…Recently Shaw and colleagues, proposed that the causal agents of ALS-PDC and other neurodegenerative disorders are sterol glucosides (Shaw and Wilson, 2003). This is consistent with their inability to observe any behavioral or neuropathological effects when they administered L-BMAA to mice (CruzAguado et al, 2006).…”
Section: In Vivo Studies Of Bmaa Neurotoxicitymentioning
confidence: 74%
“…This data challenge the hypothesis of Shaw and colleagues that sterol glucosides are the causal factors for ALS-PDC and other neurodegenerative diseases Wilson et al, 2002;Shaw and Wilson, 2003). In their most recent review (Ly et al, 2007) they acknowledge the existence of cycad sterol glucosides in many plants, mentioning that their amount in cycad seeds is several orders of magnitude higher compared with other plants and that the critically important point is the dose of exposure.…”
Section: In Vivo Studies Of Bmaa Neurotoxicitymentioning
confidence: 89%
See 3 more Smart Citations